The Pharma Letter Podcast — Episode 31 — How real-time data could transform clinical trials

In this week’s podcast, we welcome Iddo Peleg, CEO and co-founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. 

As we move headlong into 2025, a year that appears set to be characterized by global economic and political turmoil, Iddo discusses major trends in the industry, including challenges posed by the COVID-19 aftermath and the potential impacts of regulatory upheaval on clinical trials. 

He also outlines how Yonalink’s technology, which streams data from electronic health records to clinical trial databases, can dramatically reduce timelines and improve accuracy in clinical studies. 

The conversation delves into the practicalities and potentials of decentralized and distributed clinical trials, offering advice to young biotech startups on leveraging the right technology for innovation.